by Peter R | Nov 20, 2019 | News, News-2019
News & Events News TriSalus Life Sciences’ Surefire® Spark™ Infusion System (TriNav™) Receives CMS Approval for Transitional Pass-Through Payment Status Designed to Improve Therapeutic Distribution and Penetration in Solid Tumors November 20, 2019—TriSalus™ Life...
by Peter R | Jul 24, 2019 | News, News-2019
News & Events News TriSalus Appoints Two New Members to Its Board of Directors July 24, 2019—TriSalus™ Life Sciences announced the election of Diane Parks and Yongxin Han to its Board of Directors, effective immediately. The appointment of two new members of the...
by Peter R | Jun 27, 2019 | News, News-2019
News & Events News TriSalus Life Sciences Forms World-Class Scientific Advisory Board to Accelerate Advancement of Strategy to Deliver Therapeutics to Solid Tumors June 27, 2019– TriSalus™ Life Sciences, an oncology company focused on overcoming infusion...
by Peter R | May 11, 2019 | Uncategorized
News & Events News TriSalus Life Sciences’ Pressure-Enabled Drug Delivery™ (PEDD™) Increases Penetration and Antitumor Activity of Anti-CEA CAR-T in Mouse Model of Liver Metastases High-pressure PEDD delivery of chimeric antigen receptor T cell (CAR-T) significantly...
Recent Comments